Literature DB >> 17991173

Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies.

Annemarie C de Vries1, Ernst J Kuipers.   

Abstract

Gastric cancer is one of the most common cancers worldwide; however, gastric cancer incidence varies greatly between different geographic areas. As gastric cancer is usually diagnosed at an advanced stage, the disease causes considerable morbidity and mortality. To detect gastric carcinomas at an early and curable stage, screening and surveillance seem necessary. Premalignant gastric lesions are well known risk factors for the development of intestinal type gastric adenocarcinomas. In a multistep cascade, chronic Helicobacter pylori-induced gastritis progresses through premalignant stages of atrophic gastritis, intestinal metaplasia and dysplasia, to eventually gastric cancer. Therefore, this cascade may provide a basis for early detection and treatment of gastric cancer. Epidemiology of gastric cancer and premalignant gastric lesions should guide the development of screening and surveillance strategies, as distinct approaches are required in countries with low and high gastric cancer incidences.

Entities:  

Mesh:

Year:  2007        PMID: 17991173     DOI: 10.1111/j.1523-5378.2007.00562.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  29 in total

1.  Premalignant lesions in gastric cancer.

Authors:  Kazuo Yashima; Shuji Sasaki; Masaharu Koda; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2009-12-16

Review 2.  Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA.

Authors:  Judy A Trieu; Mohammad Bilal; Hamzeh Saraireh; Andrew Y Wang
Journal:  Dig Dis Sci       Date:  2019-05       Impact factor: 3.199

3.  How Do We Manage Gastric Intestinal Metaplasia? A Survey of Clinical Practice Trends for Gastrointestinal Endoscopists in the United States.

Authors:  R Brooks Vance; Nisa Kubiliun; Kerry B Dunbar
Journal:  Dig Dis Sci       Date:  2016-03-17       Impact factor: 3.199

Review 4.  Intestinal metaplasia and anastomotic recurrence of gastric carcinoma.

Authors:  Elroy Patrick Weledji; George Enow Orock; Marcelin Ngowe Ngowe
Journal:  J Gastrointest Oncol       Date:  2014-12

5.  Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.

Authors:  Davide Campana; Davide Ravizza; Piero Ferolla; Antongiulio Faggiano; Franco Grimaldi; Manuela Albertelli; Claudio Ricci; Donatella Santini; Nicole Brighi; Nicola Fazio; Annamaria Colao; Diego Ferone; Paola Tomassetti
Journal:  Endocrine       Date:  2016-09-03       Impact factor: 3.633

6.  Follow-up of intestinal metaplasia in the stomach: When, how and why.

Authors:  Angelo Zullo; Cesare Hassan; Adriana Romiti; Michela Giusto; Carmine Guerriero; Roberto Lorenzetti; Salvatore Ma Campo; Silverio Tomao
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

Review 7.  Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style.

Authors:  Allyson J Merrell; Ben Z Stanger
Journal:  Nat Rev Mol Cell Biol       Date:  2016-03-16       Impact factor: 94.444

8.  Gastric intestinal metaplasia and early gastric cancer in the west: a changing paradigm.

Authors:  Justin M Gomez; Andrew Y Wang
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-06

9.  Overview of Current Concepts in Gastric Intestinal Metaplasia and Gastric Cancer.

Authors:  David S Jencks; Jason D Adam; Marie L Borum; Joyce M Koh; Sindu Stephen; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-02

10.  Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study.

Authors:  Adeyinka O Laiyemo; Farin Kamangar; Pamela M Marcus; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol       Date:  2009-10-01       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.